Status:
RECRUITING
3D Specimen Maps for RT Planning
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
28+ years
Brief Summary
The primary objective of this study is to measure the impact of patient-specific 3D specimen maps on adjuvant radiation treatment volumes and doses to critical organs. All patients will receive standa...
Detailed Description
It is estimated that 65,000 new cases of head and neck squamous cell carcinoma (HNSCC) were diagnosed in the United States in 2020. The incidence of HNSCC is projected to increase 30% worldwide by 203...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
January 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 26 2025
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT05743569
Start Date
January 26 2023
End Date
December 26 2025
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Medical Center
Nashville, Tennessee, United States, 37232